AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT03715569 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Biomarker
Description: Biomarker examination
Study NCT03715569 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: MOCA, eGOS
Description: Cognitive tests
Study NCT03715569 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Audiometry
Description: Hearing test
Study NCT02508727 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: MRI
Study NCT02508727 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: 3D cardiac ultrasound
Study NCT02136823 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: sugar pill
Study NCT02136823 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Riluzole
Study NCT02136823 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Isradipine
Study NCT02136823 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Memantine
Study NCT01307358 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Sonicare Interproximal (IP) Cleaning Prototype
Description: Sonicare Interproximal (IP) Cleaning Prototype used to clean between the teeth 1 time a day in combination with brushing.
Study NCT00057811 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: rasburicase
Description: Given IV
Study NCT00057811 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: leucovorin calcium
Description: Given IV or orally
Study NCT00057811 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: prednisone
Description: Given IV or orally
Study NCT00057811 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: methylprednisolone
Description: Given IV or orally
Study NCT00057811 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: filgrastim
Description: Given subcutaneously
Study NCT00057811 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: rituximab
Description: Given IV
Study NCT00057811 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cytarabine
Description: Given IT
Study NCT00057811 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: etoposide
Description: Given IV
Study NCT00057811 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: vincristine sulfate
Description: Given IV
Study NCT00057811 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: hydrocortisone sodium succinate
Description: Given IT
Study NCT00057811 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: laboratory biomarker analysis
Description: Correlative studies
Study NCT03356873 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vitamin D
Description: Vitamin D supplementation
Study NCT03356873 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study NCT04039880 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Olorofim
Description: single oral dose (120 mg, 3.7 MBq)
Study NCT03774199 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: NightOwl
Description: The NightOwl is a finger and/or forehead mounted device with, among other functions, the capability to acquire double-wavelength PPG, from which SpO2 can be derived
Study NCT02109458 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Navigation guided bronchoscopy
Description: Navigation guided transthoracic needle aspiration (N-TTNA) and navigation guided bronchoscopy (NB); guidance system is by Veran Medical Technologies, Inc.
Study NCT01710280 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: High-fat meal containing native palm olein
Study NCT01710280 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: High-fat meal containing interesterified palm olein
Study NCT04448730 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: serum marker levels
Description: two groups comparisons
Study NCT03277248 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Ublituximab
Description: Administered as an IV infusion.
Study NCT03277248 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Teriflunomide
Description: Film coated tablets administered orally.
Study NCT03277248 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oral Placebo
Description: Administered orally.
Study NCT02136823 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Therapeutic muscle stretching
Study NCT02130726 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Minimally-invasive gastrectomy
Description: Patients allocated to the 'Minimally-invasive gastrectomy' arm will receive total gastrectomy via laparoscopy.
Study NCT02130726 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Open Gastrectomy
Description: patients allocated to the 'Open gastrectomy' group will receive total gastrectomy via laparotomy
Study NCT01455571 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HM781-36B
Description: Q1DX14/2W for 3W HM781-36B
Study NCT01193790 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Coblation channeling
Description: The combination of the energy and the fluid creates a plasma field containing highly ionized particles (coblation). The ionized particles have sufficient energy to break organic molecular bonds that can remove tissue selectively without excessive heat production and subsequent damage to the surrounding tissue. Treatment of the tonsillar crypts and tissue by coblation may decrease antigen and immune system interaction and inflammation.
Study NCT02431585 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: OTHER
Intervention: gluten
Study NCT02431585 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: OTHER
Intervention: placebo
Study NCT04397068 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: phaco-vitrectomy
Description: phaco-vitrectomy. No other involvement drug or device. Standard of care procedure
Study NCT04789746 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: adapted Chicago Run running program
Description: The intervention being piloted is a 6-8 week running program modified from a running curriculum designed for school-aged children. The children will use a RaceRunner device to facilitate their participation, but this device is not explicitly evaluated in this study. Depending on transportation, they may be given access to the device in their home or school between sessions after it has been fit for them. If given access, guardians will be instructed on care and usage.
Study NCT01877330 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Interscalene block for shoulder arthroscopy
Study NCT00468767 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vernakalant Injection 20 mg/mL
Study NCT02257814 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Incredible Years Teacher Training
Study NCT02257814 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Preschool PATHS
Study NCT02257814 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Tools of the Mind
Study NCT06313281 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Preoperative Antiseptic preparation prior to transnasal skull base surgery
Description: The patient received one of three antiseptic preparation before transnasal skull base surgery
Study NCT02491658 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: UC-MSCs
Description: Psoriasis Vulgaris patients will receive 6 times UC-MSCs infusions (each time 1×10\^6/kg). The first time to fourth time will be given once a week for successive 4 weeks, then the last two times will be given once every two weeks.
Study NCT02650284 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Stryker Triathlon Primary Total Knee System
Description: Total Knee Replacement
Study NCT01638819 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Autologous Cord Blood Stem Cells
Description: One infusion of 60 ml syringe of study product
Study NCT01638819 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Saline
Study NCT02650284 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Restoris MCK Multicompartmental Knee System
Description: Bicompartmental Knee Replacement
Study NCT06344286 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Minimal enteral nutrition
Description: The babies were randomized into two groups based on whether they received MEN during TH. While the babies fed with MEN during TH constituted the study group, the control group was composed of the babies who were given the same amount of distilled water according to the same protocol. Two groups were compared in terms of demographic characteristics, clinical outcomes, NIRS and Doppler measurements.
Study NCT06344286 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Distilled water
Description: The babies were randomized into two groups based on whether they received MEN during TH. While the babies fed with MEN during TH constituted the study group, the control group was composed of the babies who were given the same amount of distilled water according to the same protocol. Two groups were compared in terms of demographic characteristics, clinical outcomes, NIRS and Doppler measurements.
Study NCT01327339 — intervention group
Intervention type: DRUG
Intervention: Ropinirole
Description: Basically there is no treatment allocation. Subjects who would be administered of ropinirole at their physician's direction will be enrolled. Dosage regimen will be recommended according to the prescribing information. Subjects will be enrolled consecutively.
Study NCT01423240 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lurasidone 20 mg
Description: Lurasidone 20 mg once daily orally in the evening
Study NCT01423240 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lurasidone 60 mg
Description: Lurasidone 60 mg once daily orally in the evening
Study NCT01423240 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo once daily orally in the evening
Study NCT04328064 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Rosuvastatin calcium 40mg
Description: Active drug -Rosuvastatin
Study NCT04328064 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Rosuvastatin calcium 40mg
Description: Active drug -Rosuvastatin
Study NCT04328064 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo oral tablet
Description: 40 mg placebo for 12 months
Study NCT04328064 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Placebo oral tablet
Description: 40 mg placebo for 12 months
Study NCT02551367 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Letrozole
Description: 2.5 mg will taken from day 2 to day 6 of the cycle , for 3 consecutive cycles
Study NCT02551367 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Clomiphene citrate
Description: 50 mg twice daily orally from day 2 to day 6 , for 3 consecutive cycles
Study NCT02285283 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Itraconazole
Study NCT02285283 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study NCT01145612 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Losartan
Description: Losartán dosage: 12.5 mg /day for patients \< 50 Kg or 25 mg/day for patients > 50 Kg (14 days). 50 mg/day from day 15 to the end of the study. Half of dose (25 mg/day) for patients \< 50 Kg
Study NCT01145612 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Atenolol
Description: Atenolol dosage: 12.5 mg /day for patients \< 50 Kg or 25 mg/day for patients > 50 Kg (14 days). 50 mg/day from day 15 to the end of the study. Half of dose (25 mg/day) for patients \< 50 Kg
Study NCT02344836 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Podcast + mobile diet app
Description: Use of a mobile app to track behaviors related to weight loss as well as receive study-related weight loss information via podcast.
Study NCT02551367 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: hcg hormone
Description: 10.000 iu im injection when follicle diameter reach 18 mm by transvaginal ultrasound
Study NCT02551367 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: hcg hormone
Description: 10.000 iu im injection when follicle diameter reach 18 mm by transvaginal ultrasound
Study NCT02344836 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Podcast + theory-based mobile diet app
Description: Use of a theory-based mobile app to track behaviors related to weight loss as well as receive study-related weight loss information via podcast.
Study NCT03704792 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: FibroScan 530 Compact
Description: The FibroScan® is a device equipped with probes (M+ or XL+), each of which consists of an ultrasonic transducer mounted on the axis of a mechanical vibrator. Liver stiffness and CAP measurements are performed on the right lobe of the liver with the patient in a dorsal decubitus and maximal abduction position. The procedure is non-invasive and painless.
Study NCT01521143 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Cvac
Description: Injections were done at 4 anatomical sites, 1 injection in each of the upper portions of both arms and both thighs.
Study NCT01521143 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Injections were done at 4 anatomical sites, 1 injection in each of the upper portions of both arms and both thighs.~Placebo consisted of the Cvac formulation buffer (5% HSA, 10% DMSO) with 0.9% simethicone provided in 1 mL vials that had been cryopreserved and stored at the manufacturing facility.
Study NCT02018809 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Medication Adherence Partner
Study NCT00906022 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Astron Pulsar Stent
Description: Stenting with Astron Pulsar
Study NCT00906022 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: PTA alone
Description: Balloon angioplasty alone
Study NCT04014504 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Neonatal Hearing Screening Test
Description: neonatal hearing screening test results will be evaluated.
Study NCT02018809 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Electronic pill bottle
Description: This device can remotely track medication taking and will be used by subjects to store once-a-day statin medication already prescribed pre-trial.
Study NCT04114994 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Boston Cognitive Assessment (BoCA)
Description: The Boston Cognitive Assessment (BoCA) is a self-administered online test intended for longitudinal cognitive monitoring. BoCA uses random not-repeating tasks to minimize learning effects. BoCA was developed to evaluate the effects of treatment in longitudinal clinical trials and available gratis to individuals and professionals.~BoCA includes eight subtests in the following domains: Memory/Immediate Recall, Memory/Delayed Recall, Executive function/ Visuospatial, Executive function/ Mental rotation, Attention, Mental math, Language/Prefrontal Synthesis, and Orientation. The maximum total score is 30. Higher score indicates better cognitive performance.~After BoCA is completed, the domain scores and total score are provided immediately. Users will also receive an email with the link to the full report with progress charts.
Study NCT03244891 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Increase of central volume
Description: Mild hypovolemia will be induced in healthy volunteers by 12 hours fasting. Three conditions will be considered for the analysis, each of them both during spontaneous breathing and positive pressure ventilation:~1. baseline~2. after fluid shift induced by passive head down position at 15 degrees~3. after fluid challenge with Ringer acetate 15ml\*kg in head down position~A total of six steps will be considered for the analysis
Study NCT03244891 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Ventilation mode
Description: Each previous step will be done in two respiratory conditions:~1. spontaneous breathing~2. noninvasive ventilation via facial mask in pressure support mode at 8 cmH2O above positive end expiratory pressure of 5 cmH2O, inspiratory fraction of oxygen of 0.25 In both conditions respiratory rate will be set at 18 breaths per min following a metronome
Study NCT04012268 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: RIC
Description: Patients allocated to the RIC group will undergo RIC procedure during which bilateral arm cuffs are inflated to a pressure of 50 mmHg over systolic blood pressure for five cycles of 5 min followed by 5 min of relaxation of the cuffs.
Study NCT04012268 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Aspirin
Description: patients will accept medication guided by neurologists
Study NCT04113031 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Flywheel squats versus free weight high load squats for explosive actions in football
Description: Over the course of the interventions, all players in all three groups will be instructed to adhere to their two-three weekly football practices and preseason matches of their team (\~one weekly match). The flywheel group performes squat resistance exercise in using a flywheel device, and the barbell free weight group performes squat resistance exercise using an Olympic barbell and weights.
Study NCT04921605 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: DragonFly transcatheter mitral valve clamping system
Description: To conduct edge-to-edge repair with Dragonfly System under the guidance of transesophageal echocardiography.
Study NCT00333515 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Human Butyrylcholinesterase (HuBChE) derived from human plasma
Description: Administration via IV infusion at a rate of 50 mg/min (2 mL/min)
Study NCT00333515 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo: Normal saline
Description: Administration via IV infusion at a rate of 50 mg/min (2 mL/min)
Study NCT04113031 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Flywheel squats versus free weight high load squats for explosive actions in football
Description: Over the course of the interventions, all players in all three groups will be instructed to adhere to their two-three weekly football practices and preseason matches of their team (\~one weekly match). The flywheel group performes squat resistance exercise in using a flywheel device, and the barbell free weight group performes squat resistance exercise using an Olympic barbell and weights.
Study NCT02018809 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Electronic pill bottle
Description: This device can remotely track medication taking and will be used by subjects to store once-a-day statin medication already prescribed pre-trial.
Study NCT00184119 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Psychiatric Intensive Care Unit
Study NCT00184119 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Care in whole acute unit
Description: psychiatric acute care as usual
Study NCT04100161 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Protein supplementation
Description: Daily dose of 40 g whey protein for 3 months
Study NCT04100161 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Carbohydrate supplementation
Description: Daily dose of 40 g maltodextrin for 3 months
Study NCT04100161 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Active rehabilitation
Description: Progressive rehabilitation following a muscle strain injury for 3 months
Study NCT04100161 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Active rehabilitation
Description: Progressive rehabilitation following a muscle strain injury for 3 months
Study NCT02404246 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Peer support program
Study NCT01051011 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: insulin glargine
Description: initial dose 10 international units (IU) sc daily, titrated according to the mean FPG, 24 (-52) weeks
Study NCT01051011 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: metformin
Description: as prescribed
Study NCT01051011 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: metformin
Description: as prescribed
Study NCT03277248 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: IV Placebo
Description: Administered as an IV Infusion.
Study NCT00857558 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: saxagliptin
Description: orally administration at 1 mg once a day for 12 weeks
Study NCT01051011 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: taspoglutide
Description: 10mg sc weekly, 24 (-52) weeks
Study NCT01051011 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: taspoglutide
Description: 10mg sc weekly the 1st 4 weeks followed by 20mg sc weekly, 24 (-52) weeks
Study NCT03780205 — intervention group
Intervention type: OTHER
Intervention: Prescription glasses for bilateral amblyopia
Description: Correction of refractive error with prescription glasses both eyes
Study NCT03780205 — intervention group
Intervention type: OTHER
Intervention: Prescription glasses for unilateral amblyopia
Description: Correction of asymmetric refractive errors with lenses